Melanoma Clinical Trials in New York

Showing 141-160 of 172 trials

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

NCT00533702

The primary objective of this study is to determine the progression-free survival (PFS) of participants with previously untreated metastatic malignant melanoma when treated with IMC-1121B (ramucirumab) alone or in combination with dacarbazine.

Metastatic Malignant Melanoma

Eli Lilly and Company106 participantsStarted Nov 2007

Decatur, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +14 more locations

COMPLETEDPHASE2< 1 mile

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

NCT00623766

To assess the response of melanoma with brain metastases to ipilimumab treatment while maintaining acceptable tolerability.

Melanoma

Bristol-Myers Squibb99 participantsStarted Jul 2008

Scottsdale, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +11 more locations

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Melanoma Trials in Other Cities

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study of CP-675,206 in Refractory Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Vaccine Therapy in Treating Patients With Malignant Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

SciBase International Melanoma Pivotal Study

Other Conditions in New York